Russell Jackson, DO
Orthopaedic Surgery · San Antonio, TXNPI 1073752879
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,600 of the $19,300 with a category attached, or 60.1%. Trice Medical, Inc. accounts for 66.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $9,478 and has fallen 98.7% since, to $119 in 2025.
Across 42 payments — averaging $459.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trice Medical, Inc.$13K
- Medinc Of Texas$3K
- Arthrex$2K
- Exactech, Inc.$665
- ERMI LLC$269
- Embody, Inc.$198
- plus $395 from 8 others
What the payments were for
- Consulting fees$11,60060%
- Travel & lodging$2,00210%
- Food & beverage$1,3177%
- Education$4,30722%
- Gifts$740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trice Medical, Inc. | 13 | $12,782 |
| Medinc Of Texas | 6 | $3,481 |
| Arthrex | 3 | $1,509 |
| Exactech, Inc. | 3 | $665 |
| ERMI LLC | 5 | $269 |
| Embody, Inc. | 1 | $198 |
| Arthrosurface Incorporated | 1 | $119 |
| Anika Therapeutics, Inc. | 2 | $79 |
| Endo Pharmaceuticals Inc. | 3 | $47 |
| Bioventus LLC | 1 | $41 |
| Stryker | 1 | $40 |
| Pfizer | 1 | $26 |
| Organogenesis Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,300 in reported general payments places this provider in the 75th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $349 |
| Tramadol Hcl | 21 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Antonio
- Stephen BurkhartSan Antonio$185.3M
- Michael WirthSan Antonio$4.5M
- Ravi KariaSan Antonio$1.1M
- Charles RockwoodSan Antonio$975K
- Christopher ChaputSan Antonio$959K
- Frank ButtacavoliSan Antonio$866K
- Robert HartzlerSan Antonio$654K
- Bernard MorreySan Antonio$639K
- Animesh AgarwalSan Antonio$408K
- Ralph GarzaSan Antonio$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.